Blackstone's record breaking $21.7bn Blackstone Capital Partners V fund has agreed to make a $500m minority investment in pharmaceutical company Stiefel Laboratories.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.